Skip to main content
Signal8

Barrow Robert

SEC insider (Form 3/4/5 filer). CIK 0001897557. Chief Executive Officer at Definium Therapeutics, Inc. (DFTX). 16 reported Form 4/5 transactions since Sep 2024; latest on Sep 25, 2026. Located in NEW YORK, NY.

Companies Barrow Robert has filed insider reports for

  • Definium Therapeutics, Inc. (DFTX): Director, Officer, Chief Executive Officer
Barrow Robert profile photo

Barrow Robert

CIK: 0001897557

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)10 (62.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Definium Therapeutics, Inc. logo
DFTX

Definium Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (16 total)

  • Definium Therapeutics, Inc. logo
    DFTX

    Definium Therapeutics, Inc.

    Sep 25, 2026
    Sale
    Direct
    31.6K shares at avg. $36.57$1.2M
  • Definium Therapeutics, Inc. logo
    DFTX

    Definium Therapeutics, Inc.

    Sep 14, 2026
    Award
    Direct
    750K shares-
  • Definium Therapeutics, Inc. logo
    DFTX

    Definium Therapeutics, Inc.

    Sep 3, 2026
    Sale
    Direct
    19K shares at avg. $37.94$722K
  • Definium Therapeutics, Inc. logo
    DFTX

    Definium Therapeutics, Inc.

    Sep 2, 2026
    Award
    Direct
    40K shares-
  • Definium Therapeutics, Inc. logo
    DFTX

    Definium Therapeutics, Inc.

    Aug 12, 2026
    Award
    Direct
    375K shares-
  • Definium Therapeutics, Inc. logo
    DFTX

    Definium Therapeutics, Inc.

    Jun 25, 2026
    Sale
    Direct
    29.2K shares at avg. $45.03$1.3M
  • Definium Therapeutics, Inc. logo
    DFTX

    Definium Therapeutics, Inc.

    Jun 22, 2026
    Award
    Direct
    375K shares-
  • Definium Therapeutics, Inc. logo
    DFTX

    Definium Therapeutics, Inc.

    Mar 25, 2026
    Sale
    Direct
    24.4K shares at avg. $18.47$451K
  • Definium Therapeutics, Inc. logo
    DFTX

    Definium Therapeutics, Inc.

    Feb 3, 2026
    Award
    Direct
    320K shares-
  • Mind Medicine (MindMed) Inc. logo
    MNMD

    Mind Medicine (MindMed) Inc.

    Dec 26, 2025
    Sale
    Direct
    25.8K shares at avg. $13.15$339K

1-10 of 16